Table 2 Patient characteristics
|  | CBCS (n = 9) | SOC (n = 11) | Total (n = 20) | |
|---|---|---|---|---|
N (%) | N (%) | N (%) | ||
Condition | Wave 2 | 5 (56%) | 6 (54%) | 11 (55%) |
Wave 3 | 4(44%) | 5 (46%) | 9 (45%) | |
Age (years) | Mean (range) | 63 (56–73) | 58 (32–72) | 60 (32–73) |
Sex | Male | 5 (56%) | 7 (64%) | 12 (60%) |
Female | 4 (44%) | 4 (36%) | 8 (40%) | |
Race | White | 5 (56%) | 8 (73%) | 13 (65%) |
Black | 4 (44%) | 2 (18%) | 6 (30%) | |
Other | 0 (0%) | 1 (9%) | 1 (5%) | |
Marital status | Single | 3 (33%) | 43 (36%) | 7 (35%) |
Married or living with partner | 3 (33%) | 5 (46%) | 8 (40%) | |
Separated, divorced, or widowed | 3 (33%) | 2 (18%) | 5 (25%) | |
Education level | < 4 year college | 4 (44%) | 9 (82%) | 13 (65%) |
≥ 4 year college | 5 (56%) | 2 (18%) | 7 (35%) | |
Insurance type | Private | 1 (11%) | 6 (55%) | 7 (35%) |
Medicaid/Medicare | 7 (78%) | 4 (36%) | 11 (55%) | |
Uninsured | 1 (11%) | 1 (9%) | 2 (10%) | |
HCV genotype | Genotype 1 | 7 (78%) | 6 (55%) | 13 (65%) |
Genotype 2 or 3 | 2 (22%) | 5 (45%) | 7 (35%) | |
HCV treatment | SOF/RBV | 2 (22%) | 4 (36%) | 6 (30%) |
SIM/SOF | 7 (78%) | 7 (64%) | 14 (70%) | |
Cirrhosis | Yes | 2 (22%) | 5 (45%) | 7 (35%) |
No | 7 (78%) | 6 (55%) | 13 (65%) | |